Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Purpose. To explore the safety and efficacy of gemcitabine and docetaxel (GEMDOC) in previously treated patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods. Patients with advanced SCCHN previously pretreated with one or two lines of pallia...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kafri, Zyad, Heilbrun, Lance K., Sukari, Ammar, Yoo, George, Jacobs, John, Lin, Ho-Sheng, Mulrenan, Heather, Smith, Daryn, Kucuk, Omer
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Scholarly Research Network 2012
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359684/
https://ncbi.nlm.nih.gov/pubmed/22655205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/159568
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak